A comprehensive view of home use/self-care. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves AstraZeneca and Amgen’s Tezspire tezepelumab in a pre-filled, single-use pen for patients aged 12 and older with severe asthma; Tezspire is the only biologic approved for severe asthma with no phenotype for use at home or doctor’s office
Published: February 02, 2023 by AstraZeneca AB
Health Canada approves Apex Labs’ take home psilocybin clinical trial; study to evaluate efficacy, safety, tolerability of APEX-52, a microdose, oral synthetic psilocybin drug product to treat depression, anxiety in adults diagnosed with PTSD
Published: January 19, 2023 by Canada Newswire
AstraZeneca’s Tezspire in new pre-filled pen approved for self-administration in EU for severe asthma patients aged 12 years and older; FDA approval on self-administration from pre-filled pen expected in first half of 2023
Published: January 13, 2023 by Alliance News
UK-based health startup Daye completes £10M funding round, which will enable it to launch world's first tampon-based at-home microbiome screening kit to test for vaginal infections, such as thrush or bacterial vaginosis
Published: October 28, 2022 by Contify Life Science News
GlobalData predicts wearable technology sector to grow 24.6%/year between 2020-2024 to reach US$156B, driven by fitness trackers, as people sought to keep fit at home during pandemic; medical wearables can be used to detect heart rate, other vital signs
Published: October 24, 2022 by GlobalData Plc

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count